MDGL
USDMadrigal Pharmaceuticals Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$488.030
고가
$494.550
저가
$477.000
거래량
0.76M
기업 기본 정보
시가총액
11.1B
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.37M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
B of A Securities Upgrades Madrigal Pharmaceuticals to Neutral, Raises Price Target to $445
B of A Securities analyst Alexandria Hammond upgrades Madrigal Pharmaceuticals from Underperform to Neutral and raises the price target from $266 to $445.
Madrigal to Present New Data from the Company's MASH Program at AASLD's The Liver Meeting 2025
Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of RezdiffraPoster of distinction examines the
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated
Truist Securities Initiates Coverage On Madrigal Pharmaceuticals with Buy Rating, Announces Price Target of $580
Truist Securities analyst Srikripa Devarakonda initiates coverage on Madrigal Pharmaceuticals with a Buy rating and announces Price Target of $580.
